NPPA and cardiac hypertrophy: Ang II exposure led to elevated mRNA and protein levels of cardiac hypertrophy indicators ANP, BNP and β-MHC, while PGAM2 silence attenuated these effects (Figure 1E-G, Supplementary Figure S1B-E).